- Home
- VERA vs FISK Comparison
VERA vs FISK Comparison
Compare VERA & FISK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- FISK
- Stock Information
- Founded
- VERA 2016
- FISK N/A
- Country
- VERA United States
- FISK
- Employees
- VERA N/A
- FISK 666
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- FISK
- Sector
- VERA Health Care
- FISK
- Exchange
- VERA Nasdaq
- FISK NYSE
- Market Cap
- VERA 2.7B
- FISK 2.5B
- IPO Year
- VERA 2021
- FISK N/A
- Fundamental
- Price
- VERA $33.37
- FISK $9.29
- Analyst Decision
- VERA Buy
- FISK
- Analyst Count
- VERA 8
- FISK 0
- Target Price
- VERA $63.50
- FISK N/A
- AVG Volume (30 Days)
- VERA 749.7K
- FISK N/A
- Earning Date
- VERA 11-07-2024
- FISK N/A
- Dividend Yield
- VERA N/A
- FISK N/A
- EPS Growth
- VERA N/A
- FISK N/A
- EPS
- VERA N/A
- FISK N/A
- Revenue
- VERA N/A
- FISK N/A
- Revenue This Year
- VERA N/A
- FISK N/A
- Revenue Next Year
- VERA N/A
- FISK N/A
- P/E Ratio
- VERA N/A
- FISK N/A
- Revenue Growth
- VERA N/A
- FISK N/A
- 52 Week Low
- VERA $14.20
- FISK N/A
- 52 Week High
- VERA $51.61
- FISK N/A
- Technical
- Relative Strength Index (RSI)
- VERA 22.57
- FISK 22.31
- Support Level
- VERA $31.77
- FISK $9.10
- Resistance Level
- VERA $36.28
- FISK $10.25
- Average True Range (ATR)
- VERA 2.18
- FISK 0.09
- MACD
- VERA -0.86
- FISK -0.05
- Stochastic Oscillator
- VERA 13.34
- FISK 16.52
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About FISK EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is the operating partner of Empire State Realty Inc. The company along with its partner manages, operates, acquires and repositions properties in Manhattan and the greater New York metropolitan area. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.